Filter
119
Filtered Results: 119
Text search:
McMahon,
R.
Featured
Recommendations
8
New Publications
17
Language
Document type
No document type
53
Guidelines
33
Studies & Reports
19
Fact sheets
6
Manuals
4
Infographics
2
Training Material
1
Strategic & Response Plan
1
Countries / Regions
Brazil
4
Sierra Leone
3
Africa
3
Kenya
2
Mozambique
2
Global
2
Tanzania
2
Eastern Europe
2
Russia
2
Ethiopia
2
Zambia
2
India
2
North Macedonia
1
Nepal
1
Colombia
1
Ghana
1
Cameroon
1
Philippines
1
Armenia
1
Germany
1
West and Central Africa
1
Paraguay
1
Belgium
1
Belarus
1
East and Southern Africa
1
South Africa
1
Papua New Guinea
1
Georgia
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
10
COVID-19
8
Studies & Reports
8
Community Health
5
Non-communicable Diseases
4
Women & Child Health
3
Capacity Building
3
Paediatrics
2
Cardiovascular Diseases
2
Yellow Fever
2
Primary Health Care
2
HIV & STI
2
Age & Elderly
2
Hepatitis
1
Public Health
1
Diabetes
1
General Guidelines
1
Vector Control
1
Nutrition
1
Pediatrics
1
Child protection
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Disabilities
1
Leprosy
1
Leishmaniasis
1
Water
1
Hygiene Promotion
1
Toolboxes
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
14
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
6
Children/Adolescents Mental Disorders
6
Country specific documents
6
For Health Worker
5
HIV in Key Populations
5
Transgender People
4
PPE Personel Protective Equipment
4
Infection Control General
4
ART Drug Resistance
3
Diagnostics & Laboratory Guidance
3
SARS-CoV-2 Variants
3
Biontech/Pfizer Comirnaty
3
Primary Care
3
Planetary Health
3
Studies & Reports
3
Neurological Disorders
3
Neurological disorders, Others
3
Assessment & Studies
2
Yellow Fever
2
Drug resistance
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Moderna
2
General documents One Health
2
Infectious Diseases
2
Health Impact & Climate Change
2
Antiretroviral Treatment ART
2
Reports & Studies
2
Drugs
1
HIV in Children and mental health
1
Information & Education Material (IEC)
1
Surveillance
1
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Clinical Aspects
1
Children & Adolescents
1
Prevention Guidelines
1
Substance Use Disorders, Others
1
Training Manuals
1
Treatment Guidelines HIV
1
Eastern Europe
1
Men who have sex with men (MSM)
1
Latin America
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
IEC Substance Use Disorders
1
Laboratory
1
Cannabis
1
Clinical Guidelines
1
Context & Facts, Travel Advice
1
Surveillance & Contact tracing
1
Global Impact: Socio-economic, health services, TB & HIV
1
Subsidiarity
1
Immunization Guidelines
1
Long COVID/ Post-COVID Syndrome
1
Inactivated COVID-19 Vaccines
1
Handbooks & Manuals
1
Stress
1
Community Health Workers CHW
1
Biodiversity shift
1
Urban health
1
Mobility
1
Non-communicable Diseases NCD
1
Prevention & Strategies
1
Studies & Reports
1
Prevention & Strategies
1
Hearing Loss & Deafness
1
Autism
1
Substance Use Disorders & Addiction
1
Bipolar Affective Disorders
1
Self-harm & Suicide
1
Latin America & the Carribean
1
Community-based Mental Health Care
1
WASH
1
War, Conflict Areas & Refugees
1
Studies & Reports
1
Food & Nutrition
1
Eastern Europe and central Asia
1
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Accessed: 27.11.2019
Módulo 9
Planificación estratégica
Julio del 2017
Módulo 9: Planificación estratégica. La OMS recomienda ofrecer la PrEP a las personas con un riesgo significativo de contraer la infección por el VIH, por lo que este módulo ofrece orientación de salud pública para los encargados de ...
Módulo 4
Líderes
Julio del 2017
Módulo 4: Líderes. Este módulo tiene por objeto informar y actualizar a los líderes y a los encargados de tomar decisiones sobre la PrEP. Proporciona información sobre los beneficios y las limitaciones de la PrEP para que puedan considerar cómo pueden a...
Stand 2.10.2020
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
Updated Treatment Guidelines
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
Rethinking Health with Covid-19 Lessons and Challenges
Este e-book que integra estratégias de três Projetos PROADISUS (Lean nas Emergências, Reab pós-COVID-19 e Cuidados Paliativos) e expõe temas relevantes, relacionados à necessidade de retorno seguro de atividades hospitalares, em paralelo ...
Current Environmental Health Reports volume 7, pages 363–370 (2020)
Climate change has direct impacts on human health, but those impacts vary widely by location. Local health impacts depend on a large number of factors including specific regional climate impacts, demographics and human vulnerabil...
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
